The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Obesity and diabetes—Not only a simple link between two epidemics
Open accessAbstract
Summary: Diabetes (DM) as well as obesity, due to their increasing incidence, were recognized as epidemic by the World Health Organization. Obesity is involved not only in the aetiopathogenesis of the most common worldwide type of DM—type 2 diabetes—but also in the development of its complications. There is also increasing scientific evidence regarding the role of obesity and overweight in type 1 diabetes. Weight gain may be considered as a complication of insulin treatment but also reveals significant pathophysiological impact on various stages of the disease. Another very important aspect related to DM as well as obesity is the microbiome, which is highly variable. The function of the gut microflora, its interaction with the whole organism, and its role in the development of obesity and type 1 diabetes as well as type 2 diabetes are still not fully understood and subject of ongoing investigations. This review presents a summary of recently published results concerning the relation of obesity/overweight and DM as well as their associations with the microbiome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity in autoimmune diseases: Not a passive bystander
Versini, M., Jeandel, P.-Y., Rosenthal, E., & Shoenfeld, Y. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.07.001 · Cited by 694
Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity
Vrieze, A., Out, C., Fuentes, S., Jonker, L., Reuling, I., Kootte, R. S., van Nood, E., Holleman, F., Knaapen, M., Romijn, J. A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.034 · Cited by 578
de Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 503
Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk
Murphy, E. A., Velazquez, K. T., & Herbert, K. M. (2015) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000209 · Cited by 492
Childhood Obesity and Type 2 Diabetes Mellitus
Hannon, T. S., Rao, G., & Arslanian, S. A. (2005) · Pediatrics · doi:10.1542/peds.2004-2536 · Cited by 463
Obesity and Type 2 Diabetes in Children: Epidemiology and Treatment
Pulgaron, E. R., & Delamater, A. M. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0508-y · Cited by 457
Leptin, from fat to inflammation: old questions and new insights
Otero, M., Lago, R., Lago, F., Casanueva, F. F., Dieguez, C., Gómez-Reino, J. J., & Gualillo, O. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.11.024 · Cited by 409
Huxley, R. R., Peters, S. A. E., Mishra, G. D., & Woodward, M. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70248-7 · Cited by 383
Colosia, A., Khan, S., & Palencia, R. (2013) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s51325 · Cited by 369
Type 2 diabetes mellitus in children and adolescents
Reinehr, T. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i6.270 · Cited by 363
Reijnders, D., Goossens, G. H., Hermes, G. D. A., Neis, E. P. J. G., van der Beek, C. M., Most, J., Holst, J. J., Lenaerts, K., Kootte, R. S., Nieuwdorp, M., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.016 · Cited by 348
Type 2 Diabetes in Youth: Epidemiology and Pathophysiology
D’Adamo, E., & Caprio, S. (2011) · Diabetes Care · doi:10.2337/dc11-s212 · Cited by 315
The importance of weight management in type 2 diabetes mellitus
Wilding, J. P. H. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12384 · Cited by 314 · cited 8×
“Such complications as CVD, apnoea, and obstructive sleep seem to be especially related with obesity and diabetes.(9) Gaining more weight in T2D increases the risk of cardiometabolic complications, which are the main reason of morbidity in T2D.”
BackgroundInfluentialAssociation of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study
Uusitalo, U., Liu, X., Yang, J., Aronsson, C. A., Hummel, S., Butterworth, M., Lernmark, Å., Rewers, M., Hagopian, W., She, J.-X., et al. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.2757 · Cited by 292
Mobini, R., Tremaroli, V., Ståhlman, M., Karlsson, F., Levin, M., Ljungberg, M., Sohlin, M., Bertéus Forslund, H., Perkins, R., Bäckhed, F., et al. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12861 · Cited by 263
Role of the Gut Microbiome in Obesity and Diabetes Mellitus
Barlow, G. M., Yu, A., & Mathur, R. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615609896 · Cited by 262
Type 2 diabetes mellitus in UK children – an emerging problem
Ehtisham, S., Barrett, T. G., & Shaw, N. J. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00409.x · Cited by 247
Hwang, I., Park, Y. J., Kim, Y., Kim, Y. N., Ka, S., Lee, H. Y., Seong, J. K., Seok, Y., & Kim, J. B. (2015) · The FASEB Journal · doi:10.1096/fj.14-265983 · Cited by 206
Zhang, Q., Wu, Y., & Fei, X. (2016) · Medicina · doi:10.1016/j.medici.2015.11.008 · Cited by 197
Type 1 diabetes, metabolic syndrome and cardiovascular risk
Chillarón, J. J., Flores Le-Roux, J. A., Benaiges, D., & Pedro-Botet, J. (2014) · Metabolism · doi:10.1016/j.metabol.2013.10.002 · Cited by 195
Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States
DuBose, S. N., Hermann, J. M., Tamborlane, W. V., Beck, R. W., Dost, A., DiMeglio, L. A., Schwab, K. O., Holl, R. W., Hofer, S. E., Maahs, D. M., et al. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.05.046 · Cited by 182
Libman, I. M., Miller, K. M., DiMeglio, L. A., Bethin, K. E., Katz, M. L., Shah, A., Simmons, J. H., Haller, M. J., Raman, S., Tamborlane, W. V., et al. (2015) · JAMA · doi:10.1001/jama.2015.16174 · Cited by 181
Mathur, R., & Barlow, G. M. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1051029 · Cited by 165
Abbasi, A., Juszczyk, D., van Jaarsveld, C. H. M., & Gulliford, M. C. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00044 · Cited by 165
Effects of a high fat diet on intestinal microbiota and gastrointestinal diseases
Zhang, M., & Yang, X.-J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i40.8905 · Cited by 162
Effectiveness of probiotics in type 2 diabetes: a meta-analysis
Kasińska, M., & Drzewoski, J. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3156 · Cited by 144
Rodrigues, R. R., Greer, R. L., Dong, X., DSouza, K. N., Gurung, M., Wu, J. Y., Morgun, A., & Shulzhenko, N. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02306 · Cited by 135
Minges, K. E., Whittemore, R., WEINZIMER, S. A., Irwin, M. L., Redeker, N. S., & Grey, M. J. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.01.012 · Cited by 131
Fröhlich-Reiterer, E. E., Rosenbauer, J., Pozza, S. B., Hofer, S. E., Schober, E., Holl, R. W., & on behalf of the DPV-Wiss Study Group and the German BMBF Competence Networks Diabetes mellitus and Obesity (2014) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-304237 · Cited by 128
Sun, J., & Buys, N. J. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516000076 · Cited by 122
Diet Effects in Gut Microbiome and Obesity
Chen, J., He, X., & Huang, J. (2014) · Journal of Food Science · doi:10.1111/1750-3841.12397 · Cited by 122
Akbari, V., & Hendijani, F. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw039 · Cited by 115
Probiotics for the management of type 2 diabetes mellitus: A systematic review and meta-analysis
Samah, S., Ramasamy, K., Lim, S. M., & Neoh, C. F. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.06.014 · Cited by 112
Li, C., Li, X., Han, H., Cui, H., Peng, M., Wang, G., & Wang, Z. (2016) · Medicine · doi:10.1097/md.0000000000004088 · Cited by 112
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism
Mikkelsen, S. U., Frost, M., Bahl, M. I., Licht, T. R., Jensen, U. S., Rosenberg, J., Pedersen, O. B., Hansen, T. F., Rehfeld, J. F., Holst, J. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142352 · Cited by 110
Trends in diabetes and obesity in Samoa over 35 years, 1978–2013
Lin, S., Naseri, T. K., Linhart, C., Morrell, S. L., Taylor, R. J., McGarvey, S. T., Magliano, D. J., & Zimmet, P. (2016) · Diabetic Medicine · doi:10.1111/dme.13197 · Cited by 90
Amiri, E. A., Abdullatif, M., Abdulle, A. M., Bitar, N. A., Afandi, E. Z., Parish, M., & Darwiche, G. (2015) · BMC Public Health · doi:10.1186/s12889-015-2649-6 · Cited by 89
Efficacy and Safety of Metformin for Patients with Type 1 Diabetes Mellitus: A Meta-Analysis
Liu, C., Wu, D., Zheng, X., Li, P., & Li, L. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0190 · Cited by 78
Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes
Price, S. A., Gorelik, A., Fourlanos, S., Colman, P. G., & Wentworth, J. M. (2014) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2013.03.007 · Cited by 77
Nansel, T. R., Lipsky, L. M., & Iannotti, R. J. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.025 · Cited by 64
Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents
Abdelghaffar, S., & Attia, A. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006691.pub2 · Cited by 58
Sidhu, M., & van der Poorten, D. (2017) · PubMed · Cited by 57
Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit
Hill, C. J., Cardwell, C. R., Maxwell, A. P., Young, R. J., Matthews, B. B., O'Donoghue, D. J., & Fogarty, D. G. (2013) · QJM · doi:10.1093/qjmed/hct123 · Cited by 54
Obesity and the gut microbiome: pathophysiological aspects
Bradlow, H. L. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0063 · Cited by 53
Nwosu, B. U., Maranda, L., Cullen, K., Greenman, L., Fleshman, J., McShea, N., BARTON, B. A., & Lee, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137525 · Cited by 50
Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?
Otto-Buczkowska, E., & Jainta, N. (2017) · Intern J Endocrinol Metab · doi:10.5812/ijem.13008 · Cited by 47
Excess weight gain during insulin pump therapy is associated with higher basal insulin doses
Boucher‐Berry, C., Parton, E. A., & Alemzadeh, R. (2016) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-016-0271-5 · Cited by 38
Burchardt, P., Zawada, A. E., Tabaczewski, P., Naskręt, D., Kaczmarek, J., Marcinkaniec, J., Wierusz‐Wysocka, B., & Wysocki, H. (2013) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1925 · Cited by 28
Konrad, K., Datz, N., Engelsberger, I., Grulich‐Henn, J., Hörtenhuber, T., Knauth, B., Meißner, T., Wiegand, S., Woelfle, J., Holl, R. W., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12203 · Cited by 24
The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus
Munir, K. M., & Davis, S. N. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1084502 · Cited by 22
Huang, J. S., Gottschalk, M. E., Norman, G. J., Calfas, K. J., Sallis, J. F., & Patrick, K. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-29 · Cited by 19
Burchardt, P., Zawada, A. E., Kaczmarek, J., Marcinkaniec, J., Wysocki, H., Wierusz‐Wysocka, B., Grzymislawski, M. B., Rzeźniczak, J., Zozulińska‐Ziółkiewicz, D., & Naskręt, D. (2016) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3527 · Cited by 19
Minges, K. E., Whittemore, R., Chao, A. M., Jefferson, V., Murphy, K. M., & Grey, M. J. (2016) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721716654006 · Cited by 18
Any role for probiotics in the therapy or prevention of autoimmune diseases? Up-to-date review
Özdemır, Ö. (2013) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2012-0054 · Cited by 14
Differential association of body mass index on glycemic control in type 1 diabetes
Lee, E. Y., Lee, Y., Jin, S., Yang, H. K., Jung, C. H., Park, C., Cho, J., Lee, W. J., Lee, B., & Kim, J. H. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2815 · Cited by 12
Collier, A., Connelly, P. J., Hair, M. D., Cameron, L., Ghosh, S. K., & Waugh, N. R. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13334 · Cited by 11
Deeb, A., Attia, S., Samia, M., et al. (2017) · Journal of Diabetes and Obesity · doi:10.15436/2376-0494.17.1389 · Cited by 7
Cited by
Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
Ruze, R., Liu, T., Zou, X., Song, J., Chen, Y., Xu, R., Yin, X., & Xu, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1161521 · Cited by 799
Thingholm, L. B., Rühlemann, M. C., Koch, M., Fuqua, B., Laucke, G., Boehm, R., Bang, C., Franzosa, E. A., Hübenthal, M., Rahnavard, A., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.07.004 · Cited by 451
Carbone, S., Del Buono, M. G., Ozemek, C., & Lavie, C. J. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.08.004 · Cited by 327
Intervertebral disc degeneration: A focus on obesity and type 2 diabetes
Cannata, F., Vadalà, G., Ambrosio, L., Fallucca, S., Napoli, N., Papalia, R., Pozzilli, P., & Denaro, V. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3224 · Cited by 144
Probiotics for the treatment of type 2 diabetes: A review of randomized controlled trials
Tiderencel, K. A., Hutcheon, D. A., & Ziegler, J. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3213 · Cited by 82
Metadata
- Authors
- Chobot, A., Górowska‐Kowolik, K., Sokołowska, M., & Jarosz‐Chobot, P.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2018-07-17
- Volume
- 34
- Issue
- 7
- Pages
- e3042-e3042
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W2809260887
- Cited by
- 281
- References
- 57
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.